Invion (AU:IVX) has released an update.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Invion Limited has issued over half a million new shares and is in talks with RMW Cho Group Limited to potentially expand its Photosoft™ technology rights. Known for advancing photodynamic therapy for cancer treatment, Invion is leveraging its ASX listing to drive innovation in the medical field. These developments could impact the company’s market position and attract investor interest.
For further insights into AU:IVX stock, check out TipRanks’ Stock Analysis page.